Stocks360

Waverunner Capital Inc. (CHM.CN)

Stock analysis · CNQ · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
3.37
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

Waverunner Capital Inc. (CHM.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Waverunner Capital Inc.

Waverunner Capital Inc., established in North Vancouver, Canada, in 2008, is a venture capital firm that funds various stages of business development. The company specializes in early-stage, seed, and startup financing, alongside Private Investment in Public Equity (PIPEs), bridge funding, recapitalizations, and providing growth capital. It also acquires secondary limited partner interests. Waverunner Capital actively seeks investment opportunities across Europe and North America, deploying capital from its own balance sheet and personal funds. The firm typically targets equity investments ranging from Can$500,000 (US$345 million) to Can$1 million (US$694 million), focusing on companies with an enterprise value between Can$2 million (US$138 million) and Can$5 million (US$347 million). Its diverse portfolio includes stakes in the resources industry, renewable energy projects (both wind and solar), a plant-based wellness company, and a biotechnology venture aimed at consumers. The company adopted its current name, Waverunner Capital Inc., in June 2024, having previously been known as Chemistree Technology Inc.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap